Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells: Molecular Therapy - Methods & Clinical Development
Por um escritor misterioso
Descrição
Frontiers Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells: Molecular Therapy - Methods & Clinical Development
Issue: Molecular Therapy - Methods & Clinical Development
Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells - ScienceDirect
Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells - ScienceDirect
Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells: Molecular Therapy - Methods & Clinical Development
First soluble TCR therapy opens 'new universe' of cancer targets
Construct design, and expression in rhesus macaque T cells. (a)
Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells: Molecular Therapy - Methods & Clinical Development
Engineering and Design of Chimeric Antigen Receptors: Molecular Therapy - Methods & Clinical Development
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques. - Abstract - Europe PMC
A single-chain antibody generation system yielding CAR-T cells with superior antitumor function
de
por adulto (o preço varia de acordo com o tamanho do grupo)